Dermatomyositis (DM) is a chronic, systemic autoimmune disease affecting the skin, muscle, and lungs. The activation of CB2R has been shown to reduce several, key proinflammatory cytokines implicated in DM. Our group previously that expression was significantly increased DM skin compared blood, possibly due production local inflammatory cytokines. stimulation alleviates response by down-regulat...